GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microbix Biosystems Inc (TSX:MBX) » Definitions » Price-to-Owner-Earnings

Microbix Biosystems (TSX:MBX) Price-to-Owner-Earnings : 33.00 (As of May. 09, 2024)


View and export this data going back to 1992. Start your Free Trial

What is Microbix Biosystems Price-to-Owner-Earnings?

As of today (2024-05-09), Microbix Biosystems's share price is C$0.33. Microbix Biosystems's Owner Earnings per Share (TTM) ended in Dec. 2023 was C$0.01. It's Price-to-Owner-Earnings for today is 33.00.


The historical rank and industry rank for Microbix Biosystems's Price-to-Owner-Earnings or its related term are showing as below:

TSX:MBX' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 23.21   Med: 43.18   Max: 840
Current: 23.93

During the past 13 years, the highest Price-to-Owner-Earnings of Microbix Biosystems was 840.00. The lowest was 23.21. And the median was 43.18.


TSX:MBX's Price-to-Owner-Earnings is ranked better than
66.67% of 165 companies
in the Biotechnology industry
Industry Median: 34.57 vs TSX:MBX: 23.93

As of today (2024-05-09), Microbix Biosystems's share price is C$0.33. Microbix Biosystems's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.03. Therefore, Microbix Biosystems's PE Ratio for today is 12.22.

As of today (2024-05-09), Microbix Biosystems's share price is C$0.33. Microbix Biosystems's EPS without NRI for the trailing twelve months (TTM) ended in was C$0.03. Therefore, Microbix Biosystems's PE Ratio without NRI for today is 12.22.

During the past 13 years, Microbix Biosystems's highest PE Ratio without NRI was 830.00. The lowest was 12.04. And the median was 40.00.


Microbix Biosystems Price-to-Owner-Earnings Historical Data

The historical data trend for Microbix Biosystems's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microbix Biosystems Price-to-Owner-Earnings Chart

Microbix Biosystems Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 630.00 46.36 -

Microbix Biosystems Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 51.25 - - - 27.86

Competitive Comparison of Microbix Biosystems's Price-to-Owner-Earnings

For the Biotechnology subindustry, Microbix Biosystems's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Microbix Biosystems's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Microbix Biosystems's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Microbix Biosystems's Price-to-Owner-Earnings falls into.



Microbix Biosystems Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Microbix Biosystems's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.33/0.01
=33.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Microbix Biosystems  (TSX:MBX) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Microbix Biosystems Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Microbix Biosystems's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Microbix Biosystems (TSX:MBX) Business Description

Traded in Other Exchanges
Address
265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3
Microbix Biosystems Inc develops biological products and technologies. The company manufactures and develops cell culture-based biological products and technologies. It has developed and acquired two technologies; Kinlytic and LumiSort. The company's operating segment includes Antigen, QAPs DxTM and Other Includes Kinlytic. It generates maximum revenue from the Antigen QAPs segment. Geographically, it derives a majority of revenue from North America.
Executives
James Stuart Currie Senior Officer

Microbix Biosystems (TSX:MBX) Headlines

No Headlines